Physician profile
Yvette E Fields
NPI 1679795785
$1,054.42
in general payments reported to CMS, 2019-2025
14 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.89 · 2022: $262 · 2023: $168 · 2024: $169 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $249.70 | 2021-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $230.60 | 2021-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $149.32 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $83.85 | 2022-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $60.68 | 2024 | Omnipod |
| Glaxosmithkline, LLC. | $59.58 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $49.06 | 2023-2024 | |
| Novo Nordisk INC | $34.66 | 2025 | Ozempic, Wegovy |
| Tandem Diabetes Care, INC. | $32.19 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $25.82 | 2025 | |
| Amgen INC. | $21.59 | 2023 | Prolia, Evenity |
| Sanofi-Aventis U.S. LLC | $21.31 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.88 | 2024 | Jardiance |
| Astellas Pharma US INC | $17.18 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.